West Pharmaceutical Services, Inc. Forecast, price target & analysts
West Pharmaceutical Services, Inc. Target price 2026 - Analyst rating & recommendation
West Pharmaceutical Services, Inc. Classifications & Recommendation
West Pharmaceutical Services, Inc. Price Target
| Target Price | $418.20 |
| Price | $365.01 |
| Potential |
14.57%
register free of charge
|
| Number of Estimates | 19 |
|
19 Analysts have issued a price target West Pharmaceutical Services, Inc. 2027 .
The average West Pharmaceutical Services, Inc. target price is $418.20.
This is
14.57%
register free of charge
$481.95
32.04%
register free of charge
$340.37
6.75%
register free of charge
|
|
| A rating was issued by 23 analysts: 21 Analysts recommend West Pharmaceutical Services, Inc. to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the West Pharmaceutical Services, Inc. stock has an average upside potential 2027 of
14.57%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 3.07 | 3.41 |
| 6.25% | 10.83% | |
| EBITDA Margin | 20.53% | 27.84% |
| 20.25% | 35.59% | |
| Net Margin | 16.06% | 18.70% |
| 5.69% | 16.44% |
20 Analysts have issued a sales forecast West Pharmaceutical Services, Inc. 2026 . The average West Pharmaceutical Services, Inc. sales estimate is
This results in the following potential growth metrics:
18 Analysts have issued an West Pharmaceutical Services, Inc. EBITDA forecast 2026. The average West Pharmaceutical Services, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
19 West Pharmaceutical Services, Inc. Analysts have issued a net profit forecast 2026. The average West Pharmaceutical Services, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 6.79 | 9.05 |
| 1.49% | 33.28% | |
| P/E | 40.34 | |
| EV/Sales | 7.66 |
19 Analysts have issued a West Pharmaceutical Services, Inc. forecast for earnings per share. The average West Pharmaceutical Services, Inc. EPS is
This results in the following potential growth metrics and future valuations:
West Pharmaceutical Services, Inc....
Current West Pharmaceutical Services, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Sep 22 2026 |
| UBS |
Locked
➜
Locked
|
Locked | Sep 09 2026 |
| Citigroup |
Locked
➜
Locked
|
Locked | Aug 03 2026 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Jul 27 2026 |
| BNP Paribas |
Locked
➜
Locked
|
Locked | Jul 13 2026 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Jul 09 2026 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Jul 06 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Sep 22 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
Sep 09 2026 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Aug 03 2026 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Jul 27 2026 |
|
Locked
BNP Paribas:
Locked
➜
Locked
|
Jul 13 2026 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Jul 09 2026 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Jul 06 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
